chevron_leftBack
As of 13 June 2026, Embecta Corp. has a market cap of $183.92M USD, ranking #21618 globally and #3504 in the United States.
It ranks #1937 in the Healthcare sector, and #400 in the Medical Devices industry.
Key Stats
Market Cap
$183.92MUSD
Enterprise Value
$1.73BUSD
Revenue (TTM)
$1.08BUSD
EBITDA (TTM)
$366.7MUSD
Net Income (TTM)
$139.5MUSD
EBITDA Margin
34%
Profit Margin
13%
PE Ratio
3.7
Forward PE
3.1
PS Ratio
0.5
EV/EBITDA
4.7
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Devdatt Kurdikar
open_in_new
Employees
1,850
Founded
1924
Website
embecta.com
open_in_new
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -3.6% | -4.2% | 2.1% | -14% | -38% | -29% |
News
Loading...
EMBC Analyst Forecasts
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
EMBC
Embecta Corp
ISIN: US29082K1051
Shares Out.:
Shares Outstanding:
59.328M1
Shares Float:
54.672M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
NQ:
NASDAQ:
BA:
Barron's:
MS:
Morningstar:
|
8.71 USD | |
|
EMBC
Embecta Corp
ISIN: US29082K1051
Shares Out.:
Shares Outstanding:
58.485M1
Shares Float:
54.307M2
|
497.96 MXN | |
|
JX7
Embecta Corp
ISIN: US29082K1051
|
7.51 EUR |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Embecta Corp.
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company’s products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient’s diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: TMO
|
$173.27B
94K%
|
25.8
|
|
NASDAQ: ISRG
|
$160.73B
87K%
|
56.7
|
|
NYSE: ABT
|
$159.07B
86K%
|
25.6
|
|
NYSE: DHR
|
$126.55B
69K%
|
34.7
|
|
NYSE: SYK
|
$120.69B
66K%
|
38.3
|
|
NYSE: BSX
|
$84.93B
46K%
|
24.5
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: MDT
|
$101.9B
55K%
|
22.2
|
|
EPA: EL
|
$97.46B
53K%
84.32B EUR
|
36.7
|
|
TSE: 7741
|
$61.41B
33K%
9.83T JPY
|
40.0
|
|
XETRA: SHL
|
$45.47B
25K%
39.34B EUR
|
18.7
|
|
SIX: ALC
|
$36.38B
20K%
28.99B CHF
|
37.9
|
|
|
$30.06B
16K%
203.66B CNY
|
26.0
|
chevron_leftBack